AC
ABBV icon

Apella Capital’s AbbVie ABBV Stock Holding History

Apella Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24M Buy
20,565
+267
+1% +$57.4K 0.07% 162
2026
Q1 		$4.23M Buy
20,298
+10,041
+98% +$2.23M 0.06% 177
2025
Q4 		$2.34M Buy
10,257
+563
+6% +$128K 0.05% 188
2025
Q3 		$2.2M Buy
9,694
+524
+6% +$107K 0.05% 179
2025
Q2 		$1.72M Buy
9,170
+343
+4% +$63.7K 0.05% 175
2025
Q1 		$1.59M Buy
8,827
+756
+9% +$147K 0.05% 150
2024
Q4 		$1.43M Buy
8,071
+1
+0% +$184 0.06% 140
2024
Q3 		$1.59M Buy
8,070
+501
+7% +$93.5K 0.07% 121
2024
Q2 		$1.27M Buy
7,569
+204
+3% +$33.8K 0.06% 134
2024
Q1 		$1.25M Buy
7,365
+104
+1% +$17.9K 0.06% 127
2023
Q4 		$1.17M Sell
7,261
-151
-2% -$22K 0.07% 125
2023
Q3 		$1.1M Buy
7,412
+315
+4% +$46.2K 0.08% 110
2023
Q2 		$956K Buy
+7,097
New +$1.04M 0.07% 119
2022
Q4 		$1.57M Sell
9,709
-428
-4% -$65.6K 0.14% 81
2022
Q3 		$1.36M Buy
10,137
+1,236
+14% +$177K 0.16% 82
2022
Q2 		$1.36M Buy
8,901
+325
+4% +$49.7K 0.16% 83
2022
Q1 		$1.39M Buy
8,576
+1,150
+15% +$167K 0.2% 76
2021
Q4 		$1M Buy
7,426
+343
+5% +$40.5K 0.13% 89
2021
Q3 		$764K Buy
7,083
+69
+1% +$7.88K 0.11% 103
2021
Q2 		$790K Buy
7,014
+869
+14% +$97.9K 0.13% 109
2021
Q1 		$665K Buy
6,145
+144
+2% +$15.4K 0.21% 75
2020
Q4 		$643K Hold
6,001
– – 0.23% 73
2020
Q3 		$526K Sell
6,001
-100
-2% -$9.41K 0.21% 78
2020
Q2 		$599K Buy
6,101
+209
+4% +$18.4K 0.28% 72
2020
Q1 		$449K Buy
+5,892
New +$502K 0.26% 70

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Apella Capital's ABBV Position: Q2 2026 in Review

Apella Capital increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $57.4K and bringing the position to 20,565 shares worth $5.24M. The position accounts for 0.07% of the portfolio, ranked #162.

Apella Capital first reported a position in ABBV in Q1 2020 and has held it in 25 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Apella Capital held 20,565 shares of AbbVie worth $5.24M as of Q2 2026.
  • Apella Capital bought 267 AbbVie shares in Q2 2026, an estimated $57.4K.
  • AbbVie made up 0.07% of Apella Capital's portfolio in Q2 2026, its #162 holding.
  • Apella Capital first reported a position in AbbVie in Q1 2020 and has held it in 25 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.